Regulation of endothelial cell contacts during leukocyte extravasation

Current Opinion in Cell Biology

Volumn 14, Issue 5, 2002, Pages 587-593

  Vestweber, Dietmar ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CD31 ANTIGEN; CD99 ANTIGEN; CELL ADHESION MOLECULE; CELL PROTEIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MEMBRANE PROTEIN;

ANGIOGENESIS; ANIMAL CELL; CELL ADHESION; CELL CONTACT; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE MIGRATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TIGHT JUNCTION;

ANIMALIA;

EID: 0036775855     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(02)00372-1     Document Type: Review

References (65)

1. von Andrian U.H., Mackay C.R. T-cell function and migration. Two sides of the same coin. N Engl J Med. 343:2000;1020-1034.
2. Worthylake R.A., Burridge K. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr Opin Cell Biol. 13:2001;569-577.
3. Vestweber D. Molecular mechanisms that control endothelial cell contacts. J Pathol. 190:2000;281-291.
4. Aberle H., Schwartz H., Kemler R. Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem. 61:1996;514-523.
5. Lampugnani M.G., Resnati M., Raiteri M., Pigott R., Pisacane A., Houen G., Ruco L.P., Dejana E. A novel-endothelial specific membrane protein is a marker of cell-cell contacts. J Cell Biol. 118:1992;1511-1522.
6. Gotsch U., Borges E., Bosse R., Böggemeyer E., Simon M., Mossmann H., Vestweber D. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci. 110:1997;583-588.
7. Corada M., Mariotti M., Thurston G., Smith K., Kunkel R., Brockhaus M., Lampugnani M.G., Martin-Padura I., Stoppacciaro A., Ruco L., et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA. 96:1999;9815-9820.
8. Shaw S.K., Bamba P.S., Perkins B.N., Luscinskas F.W. Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J Immunol. 167:2001;2323-2330.
9. Lampugnani M.G., Corada M., Caveda L., Breviario F., Ayalon O., Geiger B., Dejana E. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, β-catenin, and α-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol. 129:1995;203-217.
10. Braga V.M.M., Machesky L.M., Hall A., Hotchin N.A. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J Cell Biol. 137:1997;1421-1431.
11. Braga V.M.M., Del Maschio A., Machesky L., Dejana E. Regulation of cadherin function by Rho and Rac: modulation by junction maturation and cellular context. Mol Biol Cell. 10:1999;9-22.
12. van Wetering S., van Buul J.D., Quik S., Mul F.P., Anthony E.C., Klooster J.P., Collard J.G., Hordijk P.L. Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci. 115:2002;1837-1846.
13. Daniel J.M., Reynolds A.B. Tyrosine phosphorylation and cadherin/catenin function. Bioessays. 19:1997;883-891.
14. Lampugnani M.G., Corada M., Andriopoulou P., Esser S., Risau W., Dejana E. Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J Cell Sci. 110:1997;2065-2077.
15. Ukropec J.A., Hollinger M.K., Salva S.M., Woolkalis M.J. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem. 275:2000;5983-5986.
16. Esser S., Lampugnani M.G., Corada M., Dejana E., Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci. 111:1998;1853-1865.
17. Zanetti A., Lampugnani M.G., Balconi G., Breviario F., Corada M., Lanfrancone L., Dejana E. Vascular endothelial growth factor induces Shc association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling. Arterioscler Thromb Vasc Biol. 22:2002;617-622. This study establishes the inducible association of VE-cadherin and vascular endothelial growth factor receptor 2 (VEGF-R2), which leads to the association of Shc with VE-cadherin, providing further details about interactions between VE-cadherin and VEGF-signalling.
18. Carmeliet P., Lampugnani M.-G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oosthuyse B., Dewerchin M., et al. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis. Cell. 98:1999;147-157.
19. Fachinger G., Deutsch U., Risau W. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene. 18:1999;5948-5953.
20. Bixby J.L. Ligands and signaling through receptor-type tyrosine phosphatases. IUBMB Life. 51:2001;157-163.
21. Tsukita S., Furuse M., Itoh M. Multifunctional strands in tight junctions. Nature Reviews. Mol Cell Biol. 2:2001;285-292. An excellent expert review that summarises the current knowledge on tight junctions with emphasis on the knowledge of the ultrastructure of tight junctions and on their molecular composition.
22. Martin-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., Panzeri C., Stoppacciaro A., Ruco L., Villa A., et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol. 142:1998;117-127.
23. Itoh M., Sasaki H., Furuse M., Ozaki H., Kita T., Tsukita S. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol. 154:2001;491-497. Identifies JAM-1 at tight junction strands in epithelial cells and defines JAM-1 as a potential anchor for PAR-3, an essential factor for the establishment of cell polarity that is highly conserved among species.
24. Del Maschio A., De Luigi A., Martin-Padura I., Brockhaus M., Bartfai T., Fruscella P., Adorini L., Martino G., Furlan R., De Simoni M.G., et al. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med. 190:1999;1351-1356.
25. Lechner F., Sahrbacher U., Suter T., Frei K., Brockhaus M., Koedel U., Fontana A. Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and Do not prevent leukocyte influx into the meninges after viral or bacterial infection. J Infect Dis. 182:2000;978-982.
26. 2+-switch experiments.
27. Ostermann G., Weber K.S., Zernecke A., Schroder A., Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol. 3:2002;151-158. This report defines JAM-1 as a novel ligand for LFA-1 and presents the first anti human JAM-1 antibodies that block transendothelial migration of neutrophils and lymphocytes.
28. Bazzoni G., Martinez-Estrada O.M., Mueller F., Nelboeck P., Schmid G., Bartfai T., Dejana E., Brockhaus M. Homophilic interaction of junctional adhesion molecule. J Biol Chem. 275:2000;30970-30976. This study demonstrates convincingly the dimerisation potential of JAM-1, which is in nice agreement with the important structural analysis in Kostrewa et al. (2001) [29•] .
29. Kostrewa D., Brockhaus M., D'Arcy A., Dale G.E., Nelboeck P., Schmid G., Mueller F., Bazzoni G., Dejana E., Bartfai T., et al. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J. 20:2001;4391-4398. Represents important structural evidence for the dimerisation of JAM-1, and suggests a zipper-like interaction mode reminiscent of the structural analysis of cadherin interactions.
30. Aurrand-Lions M., Duncan L., Ballestrem C., Imhof B.A. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem. 276:2001;2733-2741.
31. Palmeri D., van Zante A., Huang C.C., Hemmerich S., Rosen S.D. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J Biol Chem. 275:2000;19139-19145.
32. Aurrand-Lions M.A., Duncan L., Du Pasquier L., Imhof B.A. Cloning of JAM-2 and JAM-3: an emerging junctional adhesion molecular family? Curr Top Microbiol Immunol. 251:2000;91-98.
33. Cunningham S.A., Arrate M.P., Rodriguez J.M., Bjercke R.J., Vanderslice P., Morris A.P., Brock T.A. A novel protein with homology to the junctional adhesion molecule. J Biol Chem. 275:2000;34750-34756.
34. Liang T.W., Chiu H.H., Gurney A., Sidle A., Tumas D.B., Schow P., Foster J., Klassen T., Dennis K., DeMarco R.A., Pham T., Frantz G., Fong S. Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3. J Immunol. 168:2002;1618-1626.
35. Arrate M.P., Rodriguez J.M., Tran T.M., Brock T.A., Cunningham S.A. Cloning of Human Junctional Adhesion Molecule 3 (JAM-3) and its identification as the JAM-2 counter receptor. J Biol Chem. 276:2001;45826-45832. The human homologue of mouse JAM-2 is identified as an inducible ligand on T-lymphocytes for the endothelial homologue of mouse JAM-3, suggesting the possibility that JAM-2/JAM-3 pairs participate in lymphocyte extravasation.
36. Aurrand-Lions M., Johnson-Leger C., Wong C., Du Pasquier L., Imhof B.A. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood. 98:2001;3699-3707. This paper defines mouse JAM-2 as specific for lymphatic endothelium and lymph node high endothelial venules and presents evidence that tight junction permeability is increased upon ectopic expression of JAM-2 in epithelial cells.
37. Naik U.P., Ehrlich Y.H., Kornecki E. Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for mAb F11 with the FcγR11 receptor. Biochem J. 310:1995;155-162.
38. Ozaki H., Ishii K., Arai H., Horiuchi H., Kawamoto T., Suzuki H., Kita T. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation. Biochem Biophys Res Commun. 276:2000;873-878.
39. Bazzoni G., Martinez-Estrada O.M., Orsenigo F., Cordenonsi M., Citi S., Dejana E. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem. 275:2000;20520-20526.
40. Ebnet K., Schulz C.U., Meyer-zu-Brickwedde M.-K., Pendl G.G., Vestweber D. Junctional adhesion molecule (JAM) interacts with the PDZ domain containing proteins AF-6 and ZO-1. J Biol Chem. 275:2000;27979-27988.
41. Martinez-Estrada O.M., Villa A., Breviario F., Orsenigo F., Dejana E., Bazzoni G. Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. J Biol Chem. 276:2001;9291-9296.
42. Hamazaki Y., Itoh M., Sasaki H., Furuse M., Tsukita S. Multi-PDZ-containing protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule (JAM). J Biol Chem. 277:2001;455-461.
43. Ebnet K., Suzuki A., Horikoshi Y., Hirose T., Meyer-zu-Brickwedde M.-K., Ohno S., Vestweber D. The cell polarity protein ASIP/PAR-3 directly associates with Junctional Adhesion Molecule (JAM). EMBO J. 20:2001;3738-3748. Identifies JAM-1 as the first transmembrane protein at tight junctions with the potential to recruit the PDZ-domain protein ASIP/PAR-3, an essential factor for the establishment of cell polarity that is highly conserved among species.
44. Izumi Y., Hirose T., Tamai Y., Hirai S., Nagashima Y., Fujimoto T., Tabuse Y., Kemphues K.J., Ohno S. An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol. 143:1998;95-106.
45. Joberty G., Petersen C., Gao L., Macara I.G. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol. 2:2000;531-539.
46. Lin D., Edwards A.S., Fawcett J.P., Mbamalu G., Scott J.D., Pawson T. A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and αPKC signalling and cell polarity. Nat Cell Biol. 2:2000;540-547.
47. Qiu R.G., Abo A., Steven Martin G. A human homolog of the C. elegans polarity determinant Par-6 links Rac and Cdc42 to PKCzeta signaling and cell transformation. Curr Biol. 10:2000;697-707.
48. Suzuki A., Yamanaka T., Hirose T., Manabe N., Mizuno K., Shimizu M., Akimoto K., Izumi Y., Ohnishi T., Ohno S. Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J Cell Biol. 152:2001;1183-1196.
49. Chretien I., Marcuz A., Courtet M., Katevuo K., Vainio O., Heath J.K., White S.J., Du Pasquier L. CTX, a Xenopus thymocyte receptor, defines a molecular family conserved throughout vertebrates. Eur J Immunol. 28:1998;4094-4104.
50. Hirata K., Ishida T., Penta K., Rezaee M., Yang E., Wohlgemuth J., Quertermous T. Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J Biol Chem. 276:2001;16223-16231. First identification of ESAM, a novel endothelial adhesion molecule with similarity to the JAM family.
51. Nasdala I., Wolburg-Buchholz K., Wolburg H., Kuhn A., Ebnet K., Brachtendorf G., Samulowitz U., Kuster B., Engelhardt B., Vestweber D., et al. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J Biol Chem. 277:2002;16294-16303. First identification of ESAM as an endothelial specific protein that is expressed on blood vessels in all analysed tissues, located at tight junctions in capillaries as well as targeted to tight junctions in transfected epithelial cells.
52. Cohen C.J., Shieh J.T., Pickles R.J., Okegawa T., Hsieh J.T., Bergelson J.M. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA. 98:2001;15191-15196.
53. Newman P.J. The biology of PECAM-1. J Clin Invest. 99:1997;3-7.
54. Graesser D., Solowiej A., Bruckner M., Osterweil E., Juedes A., Davis S.J., Ruddle N.H., Engelhardt B., Madri J.A. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest. 109:2002;383-392. Based on the study of PECAM-1 deficient mice this study presents the first (antibody- independent) evidence for a role of PECAM-1 in vascular integrity and mononuclear cell extravasation.
55. Duncan G.S., Andrew D.P., Takimoto H., Kaufman S.A., Yoshida H., Spellberg J., de la Pompa J.L., Elia A., Wakeham A., Karan-Tamir B., et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol. 162:1999;3022-3030.
56. Schenkel A.R., Mamdouh Z., Chen X., Liebman R.M., Muller W.A. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol. 3:2002;143-150. This study presents the first evidence for the sequential action of endothelial membrane proteins in leukocyte transendothelial migration, identifies CD99 as a novel endothelial contact protein that is relevant for this process and defines an early PECAM-1-dependent and late CD99-dependent step.
57. Newman P.J. Switched at birth: a new family for PECAM-1. J Clin Invest. 103:1999;5-9.
58. Ilan N., Cheung L., Pinter E., Madri J.A. Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem. 275:2000;21435-21443.
59. Muller W.A., Weigl S.A., Deng X., Phillips D.M. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 178:1993;449-460.
60. Liao F., Huynh H.K., Eiroa A., Greene T., Polizzi E., Muller W.A. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med. 182:1995;1337-1343.
61. Vaporciyan A.A., DeLisser H.M., Yan H.-C., Mendiguren I.I., Thom S.R., Jones M.L., Ward P.A., Albelda S.M. Involvement of platelet-endothelial cell adhesion molcule-1 in neutrophil recruitment in vivo. Science. 262:1993;1059-1064.
62. Wakelin M.W., Sanz M.J., Dewar A., Albelda S.M., Larkin S.W., Boughton Smith N., Williams T.J., Nourshargh S. An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med. 184:1996;229-239.
63. Tomko R.P., Johansson C.B., Totrov M., Abagyan R., Frisen J., Philipson L. Expression of the adenovirus receptor and its interaction with the fiber knob. Exp Cell Res. 255:2000;47-55.
64. Carson S.D., Hobbs J.T., Tracy S.M., Chapman N.M. Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density. J Virol. 98:2001;15191-15196.
65. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D: VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 2002, in press.